TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX/CRDL

Cardiol Therapeutics Inc Class A (CRDL : TSX)

Common Stock

$2.77

CAD

-0.39 (-12.34%)

Last updated: 2026-09-10

Get CRDL alerts:

CRDL

Cardiol Therapeutics Inc Class A

Source:WealthAwesomeWealthAwesome
$1.14 (69.94%)
30 day period
$1.63$2.40$3.16Jul 29Aug 20Sep 10

Performance

1 Day

-12.34%

1 Week

-7.05%

1 Month

+31.28%

YTD

+103.68%

Key Statistics

Market Cap

$369.16M

52W High

$3.23

52W Low

$1.23

P/E Ratio

-

50 Day MA

$2.11

200 Day MA

$1.69

Beta

0.61

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/10/2026$3.13$3.13$2.73$2.77$2.77388,652
9/9/2026$3.04$3.23$3.04$3.16$3.16440,150
9/8/2026$3.04$3.08$2.99$3.06$3.06391,147
9/4/2026$2.98$3.07$2.93$3.05$3.05185,500
9/3/2026$2.97$3.03$2.88$2.98$2.98306,982
9/2/2026$3.00$3.10$2.90$3.01$3.01342,429
9/1/2026$2.73$3.03$2.71$3.03$3.03342,920
8/31/2026$2.70$2.75$2.62$2.75$2.75186,407
8/28/2026$2.87$2.90$2.65$2.70$2.70315,588
8/27/2026$2.92$3.00$2.83$2.87$2.87317,937

Analyst Price Targets

Based on analyst covering CRDL

📈

Wall Street analysts forecast CRDL stock price to rise 116.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+116.6% Upside

Current Price

C$2.77

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CRDL's historical volatility

HistoricalForecast68%95%
C$1.23C$2.77C$4.31C$5.85C$7.40C$8.94TodayMay 4Jul 8Sep 10Oct 23Dec 6Jan 18

30-Day Vol

80.6%

Annualized

90-Day Vol

61.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$3.31

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$2.94C$2.23C$3.88
60 trading daysC$3.12C$2.11C$4.62
90 trading daysC$3.31C$2.05C$5.36

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-35.85M
Profit Margin
0.00%
ROE (TTM)
-190.18%
EPS (Diluted)
-0.34
Book Value
0.21

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CRDL

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
XMF-AM Split Corp$2.39+136.63%
TLOTalon Metals Corp$11.20+34.29%
DIAMStar Diamond Corp$0.03+25.00%
AABAberdeen International Inc.$0.03+20.00%
WMWallbridge Mining Company Limited$0.12+15.00%
CJR-BCorus Entertainment Inc$0.04+14.29%
TXPTouchstone Exploration Inc$0.17+9.37%
COPRCoppernico Metals Inc.$0.43+8.18%

CRDL.TO news timeline

15 articles covering CRDL.TO, most recent first

Latest

Why Cardiol Therapeutics Inc Class A stock plummeted yesterday

Stocks

Advertisement